Physicians Realty Q1 Revenues Beat Estimates, Normalized FFO Down Y/Y

Start generating passive income through real estate.

Own a piece of your favorite cities through diversified real estate investments in the country's top markets

*Terms and conditions apply. Visit Nada's website for more details.

  • Physicians Realty Trust DOC reported Q1 2023 revenue increase of 3.0% Y/Y to $134.3 million, exceeding the consensus of $132.2 million.
  • The normalized FFO of $0.24 was lower than $0.27 a year ago.
  • Medical Office Building (MOB), which includes 269 properties, same-store cash net operating income grew 1.0% Y/Y
  • Total expenses rose to $123.4 million from $116.1 million a year ago. DOC reported net income of $10.7 million, a decline of 23.5% Y/Y in the quarter.
  • The company completed contractual commitments related to a $40.5 million development project and acquired one medical condominium unit for $1.3 million in the quarter. Investment activity totaled around $14.4 million in Q1.
  • Also, the company sold a 30,000-square-foot medical office for $2.6 million in the quarter.
  • Cash and equivalents stood at $3.36 million at the end of the quarter. 
  • "We are excited to announce the closing of our first development transaction with Northside Hospital in the high-growth suburbs of Atlanta, Georgia. The Northside Buford MOB is 100% pre-leased on 10-year lease terms. The deal adds to our long-standing partnership with Northside Hospital and comes with future development opportunities," stated John T. Thomas, President and CEO.
  • Price Action: DOC shares are trading lower by 2.22% at $14.31 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsEquitiesMid CapNewsREITHealth CareMarketsGeneralReal EstateBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!